Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy

被引:24
作者
Welsh, JS
Berta, C
Borzillary, S
Sam, C
Shickell, D
Nobile, L
Greenberg, M
Weiss, S
Detorie, N
机构
[1] Univ Wisconsin, Ctr Clin Sci, Madison, WI 53792 USA
[2] Johns Hopkins Univ Hosp, Baltimore, MD 21231 USA
[3] Virginia Commonwealth Univ, Richmond, VA 23298 USA
[4] Mayo Clin, Rochester, MN 55905 USA
关键词
prostate cancer; image-guided radiotherapy; brachytherapy; implanted markers;
D O I
10.1177/153303460400300405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate movement imposes limits on safe dose-escalation with external beam radiation therapy. If the precise daily location of the prostate is known, dose escalation becomes more feasible. We have developed an approach to dose escalation using a combination of prostate brachytherapy followed by external beam radiation therapy in which fiducial markers are placed along with I-125 seeds during transperineal interstitial permanent prostate brachytherapy. These markers serve to verify daily prostate location during the subsequent external beam radiotherapy. Prior to implementing this approach, preliminary studies were performed to test visibility of the markers. Three different 1251 seed models, as well as gold and silver marker seeds were placed within tissue-equivalent phantoms. Images were obtained with conventional x-rays (75-85 kV) and 6 MV photons from a linear accelerator. All 1251 seed models were clearly visible on conventional x-rays but none were seen with 6 MV photons. The gold markers were visible with both energies. The silver markers were visible with conventional x-rays and 6 MV x-rays, but not as clearly as the gold seeds at 6 MV. Subsequently, conventional x-rays, CT scans, and 6 MV port films were obtained in 29 patients in whom fiducial gold marker seeds were implanted into the prostate during 1251 prostate brachytherapy. To address the possibility of "seed migration" within the prostate, CT scans were repeated 5 weeks apart in 14 patients and relative positions of the gold seeds were evaluated. The repeated CT scans showed no change in intraprostatic gold marker location, suggesting minimal migration. The gold seeds were visible with conventional x-rays, CT, and 6 MV port films in all patients. During the course of external beam radiation therapy, the gold markers were visible on routine 6 MV port films and were seen in different locations from film to film suggesting prostate motion. Mean daily displacement was 4-5 mm in the anterior-posterior, and 4-5 mm in superior-inferior dimensions. Left-right displacement appeared less, averaging 2-3 mm. We conclude that implantation of gold marker seeds during prostate brachytherapy represents an easily implemented and practical means of prostate localization during subsequent image-guided external beam radiotherapy. With such markers, conformality of the external beam component can be confidently improved without expensive new equipment.
引用
收藏
页码:359 / 364
页数:6
相关论文
共 31 条
[1]   High-precision conformal radiotherapy (HPCRT) of prostate cancer -: A new technique for exact positioning of the prostate at the time of treatment [J].
Bergström, P ;
Löfroth, PO ;
Widmark, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (02) :305-311
[2]   Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms [J].
Boersma, LJ ;
van den Brink, M ;
Bruce, AM ;
Shouman, T ;
Gras, L ;
te Velde, A ;
Lebesque, JV .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (01) :83-92
[3]  
Critz FA, 1998, CANCER J SCI AM, V4, P359
[4]   PROSTATE MOTION DURING STANDARD RADIOTHERAPY AS ASSESSED BY FIDUCIAL MARKERS [J].
CROOK, JM ;
RAYMOND, Y ;
SALHANI, D ;
YANG, H ;
ESCHE, B .
RADIOTHERAPY AND ONCOLOGY, 1995, 37 (01) :35-42
[5]   A practical method to achieve prostate gland immobilization and target verification for daily treatment [J].
D'Amico, AV ;
Manola, J ;
Loffredo, M ;
Lopes, L ;
Nissen, K ;
O'Farrell, DA ;
Gordon, L ;
Tempany, CM ;
Cormack, RA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (05) :1431-1436
[6]   Pd-103 brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma [J].
Dattoli, M ;
Wallner, K ;
Sorace, R ;
Koval, J ;
Cash, J ;
Acosta, R ;
Brown, C ;
Etheridge, J ;
Binder, M ;
Brunelle, R ;
Kirwan, N ;
Sanchez, S ;
Stein, D ;
Wasserman, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (05) :875-879
[7]   Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation [J].
Dehnad, H ;
Nederveen, AJ ;
van der Heide, UA ;
van Moorselaar, RJA ;
Hofman, P ;
Lagendijk, JJW .
RADIOTHERAPY AND ONCOLOGY, 2003, 67 (03) :295-302
[8]  
Hanks GE, 1999, CANCER J, V5, P152
[9]   Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device [J].
Herman, MG ;
Pisansky, TM ;
Kruse, JJ ;
Prisciandaro, JI ;
Davis, BJ ;
King, BF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (04) :1131-1140
[10]   Ultrasound image fusion for external beam radiotherapy for prostate cancer [J].
Holupka, EJ ;
Kaplan, ID ;
Burdette, EC ;
Svensson, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (05) :975-984